{
    "clinical_study": {
        "@rank": "126020", 
        "arm_group": [
            {
                "arm_group_label": "Active tDCS", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive active tDCS stimulation for 5 sessions (20m/each) over one week."
            }, 
            {
                "arm_group_label": "Sham tDCS", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects will receive sham tDCS stimulation for 5 sessions (20m/each) over one week."
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the investigators aim to assess the clinical and neurophysiological effects\n      of a non-invasive brain stimulation technique - transcranial direct current stimulation\n      (tDCS)- on cortical plasticity and motor learning in children with cerebral palsy.\n      Investigators will use different assessment techniques, such as transcranial magnetic\n      stimulation (TMS) and kinematics (sensors) to measure changes through the trial."
        }, 
        "brief_title": "Effects of Transcranial Direct Current Stimulation (tDCS) and Motor Learning in Children With Cerebral Palsy (CP)", 
        "condition": "Cerebral Palsy", 
        "condition_browse": {
            "mesh_term": [
                "Cerebral Palsy", 
                "Paralysis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age of participants must be between 8 and 18 years old.\n\n          -  Diagnosis of spastic or mixed CP with distribution of diplegia and/or hemiplegia\n             form.\n\n          -  Gross Motor Function Classification System for Cerebral Palsy (GMFCS) level II and\n             III.\n\n          -  Manual Ability Classification System for Children with CP (MACS) level II up to IV.\n\n          -  Ability to cooperate and follow directions.\n\n        Exclusion Criteria:\n\n          -  Muscle tone reduction therapy in the past 3 months prior to study onset.\n\n          -  Upper limb orthopedic surgery in the past 3 months prior to study onset.\n\n          -  Any other form of therapy or procedure involving motor neuron junction inhibition;\n             either by biochemical and/or mechanical denervation, in the past 3 months prior to\n             study onset.\n\n          -  History of convulsive disorder in the past 2 years prior to study onset.\n\n          -  Current use of carbamazepine as anticonvulsive therapy.\n\n          -  Presence ventriculoperitoneal shunt."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852474", 
            "org_study_id": "2012-p-000629"
        }, 
        "intervention": {
            "arm_group_label": [
                "Active tDCS", 
                "Sham tDCS"
            ], 
            "description": "Subjects will receive tDCS stimulation 1x per day for 5 days (over the period of 1 week). Each session will be 20 minutes long. During active stimulation, the subject will receive stimulation for the entire 20 minutes. For Sham stimulation, the stimulation will be active only for a short time, but will remain on the scalp for the duration of 20 minutes. Both active and sham stimulation will feel the same.", 
            "intervention_name": "Transcranial Direct Current Stimulation (tDCS)", 
            "intervention_type": "Device", 
            "other_name": [
                "1x1 direct current stimulator", 
                "soterix medical", 
                "transcranial stimulation"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "motor learning", 
            "cortical plasticity", 
            "direct current stimulation"
        ], 
        "lastchanged_date": "May 23, 2014", 
        "location": {
            "contact": {
                "email": "ffregni@partners.org", 
                "last_name": "Felipe Fregni, MD PhD MPH", 
                "phone": "617-952-6156"
            }, 
            "contact_backup": {
                "email": "kmweaver@partners.org", 
                "last_name": "Kayleen M Weaver, BA", 
                "phone": "617-952-6151"
            }, 
            "facility": {
                "address": {
                    "city": "Charlestown", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02129"
                }, 
                "name": "Spaulding Rehabilitation Network Research Institute"
            }, 
            "investigator": {
                "last_name": "Felipe Fregni, MD PhD MPH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of tDCS in Cortical Plasticity and Motor Learning in Children With Cerebral Palsy", 
        "overall_contact": {
            "email": "ffregni@partners.org", 
            "last_name": "Felipe Fregni, MD PhD MPH", 
            "phone": "617-952-6156"
        }, 
        "overall_contact_backup": {
            "email": "kmweaver@partners.org", 
            "last_name": "Kayleen M Weaver, BA", 
            "phone": "617-952-6151"
        }, 
        "overall_official": {
            "affiliation": "Spaulding Rehabilitation Hospital", 
            "last_name": "Felipe Fregni, MD PhD MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Investigators will measure changes in kinematic (sensor) assessments from baseline to follow-up. The sensor will collect Inertial Measurements Units (IMU) and complex motion sensing, as measured by accelerometer/gyroscope/magnetometer of freedom motion capture.", 
            "measure": "Changes in motor assessments", 
            "safety_issue": "No", 
            "time_frame": "Approximately 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852474"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Spaulding Rehabilitation Hospital", 
            "investigator_full_name": "Felipe Fregni", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Investigators will measure change in TMS measurements from baseline to follow-up. TMS measures will consist of: motor threshold, motor evoked potentials (MEP's), transcallosal inhibition, and examinations of intracortical inhibition and facilitation.", 
            "measure": "Changes in TMS measurements", 
            "safety_issue": "No", 
            "time_frame": "Approximately 2 weeks"
        }, 
        "source": "Spaulding Rehabilitation Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Pedal with Pete", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Spaulding Rehabilitation Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}